July 20, 2016

The combined specialty pharmacy will operate as a wholly-owned subsidiary of Kroger, the company stated.

July 20, 2016

The pilot program would allow the Department of Defense to access lower pricing for prescriptions dispensed at community pharmacies.

July 15, 2016
The drug, which combines Gilead’s Sovaldi (sofosbuvir) with an NS5A inhibitor called velpatasvir, is indicated to treat all six strains of hepatitis C, 
July 15, 2016

The new 112,000 square foot facility will expand CVS Health's work to help customers with disease education and provide pharmacy and medication counseling.

July 13, 2016
Reuters is reporting that the FDA’s Arthritis Advisory Board has unanimously recommended Amgen’s biosimilar of AbbVie’s Humira, ABP 501. The panel said that the drug was similar in safety and effectiveness to Humira for rheumatoid arthritis and plaque psoriasis, and it recommended that the biosimilar should also be approved for Crohn’s disease in adults and ulcerative colitis. (Reuters)
July 8, 2016

Xolair can now be used in patients 6 to 11 years of age with moderate to severe persistent allergic asthma. 

July 7, 2016

Diplomat’s Kelly Procailo joins the ranks of the 1,900 people who've received a Board Certified Oncology Pharmacist certification. 

July 1, 2016
Humira was first approved in 2003, and has since been approved in more than 90 countries. 
June 30, 2016
Epclusa, which treats all genotypes of hepatitis C, received Priority Review and Breakthrough Therapy designations from the FDA.
June 29, 2016

The Consumer Healthcare Products Association has published a case study regarding efforts to curb teen abuse of over-the-counter cough medicine containing dextromethorphan. 

June 27, 2016

Pharmasave announced that its pharmacists have been trained to be leaders in providing medication therapy management programs.

June 27, 2016

The Price Relief, Innovation and Competition for Essential Drugs (PRICED) Act would amend the Public Health Service act to change the exclusivity period from 12 years to seven years. 

June 23, 2016

Paul McKenzie joined Biogen in February from Johnson & Johnson, where had most recently been J&J’s VP research and development for its Ethicon business. 

June 9, 2016

Meijer's accreditation for Specialty Pharmacy at Retail comes less than a year after Meijer acquired specialty pharmacy and health care company Aureus Health Services. 

June 7, 2016

The McKesson research will reveal how much progress healthcare has made on the journey to full value-based payment.

June 7, 2016

Under the partnership, Ultragenyx will initially receive an exclusive license for one of Takeda’s preclinical product candidates in a pre-determined field of use, along with the option to co-develop and co-commercialize the candidate in other therapeutic areas.

June 6, 2016

Value-based care is driving a number of positive trends within the retail pharmacy sector.

June 2, 2016

Diplomat has paid TNH — which brought in $400 million in revenue in 2015 — $65 million in cash and $10 million in Diplomat common stock. 

June 2, 2016

In a new report, the IMS Institute for Healthcare Informatics examines the growth in the oncology market in 2015 while looking forward to 2020 and examining the ways new cancer treatments are changing the healthcare landscape in terms of cost and distribution. 

June 1, 2016

DSN associate editor David Salazar examines chain pharmacy, including in-depth coverage of pharmacy technology, in this multi-page report.

June 1, 2016
The event will take place on June 7, and feature a close look at the journey of one patient named Jay. Viewers will hear about how Jay coped with a cancer diagnosis and treatment, as well as ask questions. 
June 1, 2016
The topical steroid is indicated to treat mild to moderate plaque psoriasis in patients older than 18 years of age. 
 
May 31, 2016

Zinbryta is a once-daily self-administered injection indicated to treat relapsing forms of multiple sclerosis in patients who have had an inadequate response to two or more MS therapies. 

 
May 31, 2016

Drive DeVilbiss Healthcare manufactures a complete line of durable medical equipment including mobility products, wheelchairs, personal care products and electrotherapy devices.